Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-004803
Filing Date
2023-02-13
Accepted
2023-02-13 17:37:22
Documents
1
Period of Report
2023-02-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6199
  Complete submission text file 0000899243-23-004803.txt   7576
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Issuer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address
Le-Nguyen Quoc (Reporting) CIK: 0001792062 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39122 | Film No.: 23620311